Porothramycin, a new antibiotic of the anthramycin group: Production, isolation, structure and biological activity

37Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

A new antitumor antibiotic porothramycin was produced by a new strain of Streptomyces albus1, 2). The antibiotic was isolated in two active forms, the natural free hydroxyl form (porothramycin A) or the crystalline methyl ether form (porothramycin B) depending upon the isolation process used. Structural studies established that porothramycin is a new member of the pyrrolo[1, 4]benzodiazepine group antibiotics having only one substituent on the benzene ring. The antibiotic exhibited antimicrobial activity against Gram-positive bacteria and anaerobes and significantly prolonged the survival times of mice implanted with experimental tumors. © 1988, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Tsunakawa, M., Kamei, H., Konishi, M., Miyaki, T., Oki, T., & Kawaguchi, H. (1988). Porothramycin, a new antibiotic of the anthramycin group: Production, isolation, structure and biological activity. The Journal of Antibiotics, 41(10), 1366–1373. https://doi.org/10.7164/antibiotics.41.1366

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free